Transcription factor-based drug design in anticancer drug development.
Papavassiliou
A G
AG
Department of Biochemistry, School of Medicine, University of Patras, Greece. papavas@med.upatras.gr
D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D003198:Computer Simulation; D015195:Drug Design; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008956:Models, Chemical; D008958:Models, Molecular; D009857:Oncogenes / Q000235:genetics; D012319:RNA Polymerase II / Q000378:metabolism; D013329:Structure-Activity Relationship; D014157:Transcription Factors / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D014158:Transcription, Genetic
D000970:Antineoplastic Agents; D014157:Transcription Factors; D012319:RNA Polymerase II